Literature DB >> 31436357

Macrophage HIF-2α regulates tumor-suppressive Spint1 in the tumor microenvironment.

Rosa M Susen1, Rebekka Bauer1, Catherine Olesch1, Dominik C Fuhrmann1, Annika F Fink1, Nathalie Dehne1, Arpit Jain2, Ingo Ebersberger2,3, Tobias Schmid1, Bernhard Brüne1,4,5,6.   

Abstract

In solid tumors, tumor-associated macrophages (TAMs) commonly accumulate within hypoxic areas. Adaptations to such environments evoke transcriptional changes by the hypoxia-inducible factors (HIFs). While HIF-1α is ubiquitously expressed, HIF-2α appears tissue-specific with consequences of HIF-2α expression in TAMs only being poorly characterized. An E0771 allograft breast tumor model revealed faster tumor growth in myeloid HIF-2α knockout (HIF-2αLysM-/- ) compared with wildtype (wt) mice. In an RNA-sequencing approach of FACS sorted wt and HIF-2α LysM-/- TAMs, serine protease inhibitor, Kunitz type-1 ( Spint1) emerged as a promising candidate for HIF-2α-dependent regulation. We validated reduced Spint1 messenger RNA expression and concomitant Spint1 protein secretion under hypoxia in HIF-2α-deficient bone marrow-derived macrophages (BMDMs) compared with wt BMDMs. In line with the physiological function of Spint1 as an inhibitor of hepatocyte growth factor (HGF) activation, supernatants of hypoxic HIF-2α knockout BMDMs, not containing Spint1, were able to release proliferative properties of inactive pro-HGF on breast tumor cells. In contrast, hypoxic wt BMDM supernatants containing abundant Spint1 amounts failed to do so. We propose that Spint1 contributes to the tumor-suppressive function of HIF-2α in TAMs in breast tumor development.
© 2019 The Authors. Molecular Carcinogenesis published by Wiley Periodicals, Inc.

Entities:  

Keywords:  HAI-1; HGF; hypoxia; proliferation; tumor-associated macrophages

Mesh:

Substances:

Year:  2019        PMID: 31436357     DOI: 10.1002/mc.23103

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  10 in total

Review 1.  Revisiting the HIF switch in the tumor and its immune microenvironment.

Authors:  Sophie J Cowman; Mei Yee Koh
Journal:  Trends Cancer       Date:  2021-11-04

Review 2.  Functional RNA Dynamics Are Progressively Governed by RNA Destabilization during the Adaptation to Chronic Hypoxia.

Authors:  Rebekka Bauer; Sofie Patrizia Meyer; Karolina Anna Kloss; Vanesa Maria Guerrero Ruiz; Samira Reuscher; You Zhou; Dominik Christian Fuhrmann; Kathi Zarnack; Tobias Schmid; Bernhard Brüne
Journal:  Int J Mol Sci       Date:  2022-05-22       Impact factor: 6.208

3.  HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR).

Authors:  Chang W Song; Hyunkyung Kim; Haeun Cho; Mi-Sook Kim; Sun-Ha Paek; Heon-Joo Park; Robert J Griffin; Stephanie Terezakis; Lawrence Chinsoo Cho
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

Review 4.  Metabolic reprogramming of macrophages and its involvement in inflammatory diseases.

Authors:  Chunyu Guo; Rayhanul Islam; Shichen Zhang; Jun Fang
Journal:  EXCLI J       Date:  2021-03-11       Impact factor: 4.068

Review 5.  Long Noncoding RNA: Shining Stars in the Immune Microenvironment of Gastric Cancer.

Authors:  Xian Xiao; Wen Cheng; Guixing Zhang; Chaoran Wang; Binxu Sun; Chunyuan Zha; Fanming Kong; Yingjie Jia
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

Review 6.  Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy.

Authors:  Leah Davis; Matthias Recktenwald; Evan Hutt; Schuyler Fuller; Madison Briggs; Arnav Goel; Nichole Daringer
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639

7.  The Role of TAMs in Tumor Microenvironment and New Research Progress.

Authors:  Yawei Feng; Zhiqiang Ye; Furong Song; Yufeng He; Jun Liu
Journal:  Stem Cells Int       Date:  2022-08-15       Impact factor: 5.131

Review 8.  The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies.

Authors:  Ruixue Bai; Yunong Li; Lingyan Jian; Yuehui Yang; Lin Zhao; Minjie Wei
Journal:  Mol Cancer       Date:  2022-09-08       Impact factor: 41.444

9.  Oxygen-Mediated Suppression of CD8+ T Cell Proliferation by Macrophages: Role of Pharmacological Inhibitors of HIF Degradation.

Authors:  Milos Gojkovic; Pedro P Cunha; Gabriella S Darmasaputra; Laura Barbieri; Helene Rundqvist; Pedro Veliça; Randall S Johnson
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 10.  Tumor-Associated Macrophages and Their Functional Transformation in the Hypoxic Tumor Microenvironment.

Authors:  Zicong He; Shuixing Zhang
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.